Racial Differences in the Response to Drugs — Pointers to Genetic Differences
- 3 May 2001
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (18), 1394-1396
- https://doi.org/10.1056/nejm200105033441811
Abstract
All physicians recognize that individual patients respond differently to medications, so that at so-called standard doses, a drug may have toxic effects in some patients but fail to produce the expected therapeutic effect in others. Our lack of understanding of all the factors determining such variability among individual patients is perplexing to both physicians and their patients and limits physicians' ability to individualize therapy. Consequently, prescribing drugs is an iterative process, in which physicians initially prescribe a standard dose of medication and then adjust the dose or choice of medication in response to the observed toxic or therapeutic response. For . . .Keywords
This publication has 15 references indexed in Scilit:
- Molecular Basis of Ethnic Differences in Drug Disposition and ResponseAnnual Review of Pharmacology and Toxicology, 2001
- Polymorphisms of the β 2 -Adrenergic Receptor Determine Exercise Capacity in Patients With Heart FailureCirculation Research, 2000
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?The American Journal of Cardiology, 1999
- The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.Journal of Clinical Investigation, 1998
- Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*Clinical Pharmacology & Therapeutics, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Attenuation of Isoproterenol-Mediated Vasodilatation in BlacksNew England Journal of Medicine, 1995
- Stereoselective disposition of carvedilol is determined by CYP2D6*Clinical Pharmacology & Therapeutics, 1995